Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.

Drug design, development and therapy·2015
Same author

Involvement of tristetraprolin in transcriptional activation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin.

Biochemical and biophysical research communications·2012
Same author

Retinal gene expression and visually evoked behavior in diabetic long evans rats.

Investigative ophthalmology & visual science·2011
Same author

Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells.

BMC medical genomics·2009
Same author

Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats.

Investigative ophthalmology & visual science·2009
Same author

Intravitreal steroids for macular edema: the past, the present, and the future.

Survey of ophthalmology·2008

Related Experiment Video

Updated: Jun 10, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Differentiating intraocular glucocorticoids.

Jeffrey L Edelman1

  • 1Drug Discovery, Retinal Therapeutics, Allergan Inc., Irvine, CA, USA. edelman_jeffrey@allergan.com

Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
|August 18, 2010
PubMed
Summary
This summary is machine-generated.

Intraocular glucocorticoids (GCs) like dexamethasone, triamcinolone acetonide, and fluocinolone acetonide have unique properties affecting their therapeutic value and side effects. Understanding these differences is key for treating retinal diseases.

Related Experiment Videos

Last Updated: Jun 10, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Molecular Biology

Background:

  • Corticosteroids are widely used to treat ocular inflammation.
  • Local delivery of glucocorticoids (GCs) benefits various retinal conditions, including macular edema.
  • Knowledge of intraocular GC pharmacologic activity lags behind clinical use.

Purpose of the Study:

  • Update on glucocorticoid receptor (GR) biology in the eye.
  • Discuss pharmacokinetics, delivery, and pharmacology of intraocular dexamethasone (DEX), triamcinolone acetonide (TA), and fluocinolone acetonide (FA).

Main Methods:

  • Comparative analysis of DEX, TA, and FA solubility and delivery requirements.
  • Transcriptome microarray analysis of human trabecular meshwork cells treated with DEX, TA, and FA.
  • Assessment of photoreceptor protection in animal models.

Main Results:

  • DEX, TA, and FA exhibit distinct gene expression profiles and biological responses.
  • Steroid structure, dose, and time influence gene transactivation and repression.
  • DEX and FA demonstrated significant photoreceptor protection in animal models.

Conclusions:

  • Unique pharmacokinetic and pharmacologic profiles of intraocular steroids may impact therapeutic efficacy.
  • Differences in GC profiles could influence ocular side effect profiles.
  • Future drugs may offer improved treatment for macular edema and other retinal inflammatory diseases.